A recipe for increased colorectal cancer screening rates

August 14, 2012, University of Colorado Denver

Screening for colorectal cancer (CRC) is cost-effective and saves lives by early detection. The ability to screen large numbers of individuals is especially important for states with tight health insurance budgets dealing with aging populations. However, in 2010 only 65 percent of US adults between ages 50 and 75 got the recommended screening. A University of Colorado Cancer Center study recently published in the American Journal of Managed Care demonstrates a systematic approach to improve screening rates.

"With an introductory phone call and then mailed testing kits, we saw CRC jump from 47 to 72 percent in three years. Those who were exposed to the outreach were almost four times more likely to screen," says Karin Kempe, MD, MPH, recent director of clinical prevention at Kaiser Permanente Colorado, a CU Cancer Center consortium partner.

Kempe and colleagues mailed 58,800 fecal immunochemical tests (FIT) to low-risk Kaiser members who were not up to date on screening for colorectal cancer. Members could either complete the at home and mail it back or request colonoscopy through their provider. Of these hard-to-convince patients, 26,003 completed screening with FIT or colonoscopy. The increase in screening rates was especially high in those without recent primary or visits, suggesting that the protocol reached patients who may have been unaware of or who were not previously engaged in preventive care.

"What's especially exciting is that this first test seemed to be a foot in the door to further screening," Kempe says. Patients screened first through this study tended to migrate over time into the screening program.

Still, "while those groups that usually have lower rates of screening, such as African Americans or Latinos, did improve, their response was less than the in the white and . Our current efforts are aimed at tailored interventions to increase screening rates in these groups," Kempe adds.

"Along with colleagues Holly Wolf, PhD, MSPH and Tim Byers, MD, MPH, the American Cancer Society and the Colorado Colorectal Screening Task Force, we've been strong advocates for improving screening rates in Colorado. And, in fact, Colorado has been steadily improving in CRC screening," Kempe says. "But continued effort and investment in this area is definitely required."

There are prerequisites for instituting a system like this, says Kempe, including strategies to identify low risk members appropriate for FIT, and the ability to track and manage the results of a massive number of screening kits. But results of the current study indicate that, done carefully, a protocol of phone calls and mailed kits can increase colorectal cancer screening, likely resulting in lower costs and better medical outcomes for program participants.

Explore further: Cheaper and easier isn't necessarily better in new colon cancer screening procedures

Related Stories

Cheaper and easier isn't necessarily better in new colon cancer screening procedures

October 20, 2011
Eventually, colon cancers bleed and so tests for blood in stool seem an inexpensive and noninvasive alternative to traditional colonoscopies. In fact, a recent article in the journal Cancer Prevention Research showed that ...

Study examines adherence to colorectal cancer screening recommendations

April 9, 2012
Patients for whom colonoscopy was recommended were less likely to complete colorectal cancer screening than those patients for whom fecal occult blood testing (FOBT) was recommended or those patients who were given a choice ...

ACP releases new colorectal cancer screening guidance statement

March 5, 2012
The American College of Physicians (ACP) today issued a new guidance statement for colorectal cancer screening. Colorectal cancer is the second leading cause of cancer-related deaths for men and women in the United States. ...

Recommended for you

Study: Cells of three advanced cancers die with drug-like compounds that reverse chemo failure

January 23, 2018
Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers—ovarian, prostate and breast.

'Hijacker' drives cancer in some patients with high-risk neuroblastoma

January 23, 2018
Researchers have identified mechanisms that drive about 10 percent of high-risk neuroblastoma cases and have used a new approach to show how the cancer genome "hijacks" DNA that regulates other genes. The resulting insights ...

Enzyme inhibitor combined with chemotherapy delays glioblastoma growth

January 23, 2018
In animal experiments, a human-derived glioblastoma significantly regressed when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide.

Scientists block the siren call of two aggressive cancers

January 23, 2018
Aggressive cancers like glioblastoma and metastatic breast cancer have in common a siren call that beckons the bone marrow to send along whatever the tumors need to survive and thrive.

Researchers identify a protein that keeps metastatic breast cancer cells dormant

January 23, 2018
A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases. The work sheds light ...

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.